S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Aerie PharmaceuticalsFate TherapeuticsTwist BioscienceSangamo TherapeuticsBAVARIAN NORDIC/S
SymbolNASDAQ:AERINASDAQ:FATENASDAQ:TWSTNASDAQ:SGMOOTCMKTS:BVNRY
Price Information
Current Price$21.00$14.71$23.71$8.63$8.83
52 Week RangeBuyBuyBuyHoldN/A
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldN/A
Consensus Price Target$61.36$25.00$26.33$14.00N/A
% Upside from Price Target192.21% upside69.95% upside11.03% upside62.22% upsideN/A
Trade Information
Market Cap$921.10 million$956.98 million$791.21 million$989.06 million$855.99 million
Beta0.531.79N/A2.810.61
Average Volume855,896735,777223,7731,854,077136
Sales & Book Value
Annual Revenue$24.18 million$4.74 million$25.43 million$84.45 million$79.30 million
Price / Sales39.90202.9230.3611.8210.79
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$5.01 per share$2.48 per shareN/A$3.60 per share$3.56 per share
Price / Book4.195.932.402.48
Profitability
Net Income$-232,570,000.00$-66,600,000.00$-71,230,000.00$-68,330,000.00$-57,330,000.00
EPS($4.65)($1.19)($25.51)($0.70)($0.59)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-478.81%-934.70%-204.63%-136.73%-42.42%
Return on Equity (ROE)-89.52%-50.05%-168.45%-27.32%-12.47%
Return on Assets (ROA)-69.25%-35.63%-61.41%-17.23%-9.17%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.08%0.28%0.03%N/A0.23%
Current Ratio2.52%5.61%7.18%5.63%7.93%
Quick Ratio2.35%5.61%6.96%5.63%7.52%
Ownership Information
Institutional Ownership PercentageN/A96.59%42.69%69.01%N/A
Insider Ownership Percentage8.71%23.19%29.40%1.30%N/A
Miscellaneous
Employees353104289302419
Shares Outstanding45.94 million65.39 million32.56 million115.68 million96.93 million
Next Earnings Date11/5/2019 (Estimated)11/7/2019 (Estimated)12/18/2019 (Estimated)11/14/2019 (Estimated)11/8/2019 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableNot Optionable
 Aerie PharmaceuticalsFate TherapeuticsTwist BioscienceSangamo TherapeuticsBAVARIAN NORDIC/S

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel